R. Benchaouir, M. Meregalli, A. Farini, D. 'antona, G. Belicchi et al., Restoration of human dystrophin following transplantation of exonskipping-engineered DMD patient stem cells into dystrophic mice, Cell Stem Cell, vol.1, pp.646-57, 2007.

S. M. Chirieleison, J. M. Feduska, R. C. Schugar, Y. Askew, and B. M. Deasy, Human muscle-derived cell populations isolated by differential adhesion rates: phenotype and contribution to skeletal muscle regeneration in mdx/SCID mice, Tissue Eng Part A, vol.18, pp.232-273, 2012.

K. J. Mitchell, A. Pannérec, B. Cadot, A. Parlakian, V. Besson et al., Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development, Nat Cell Biol, vol.12, pp.257-66, 2010.

E. Negroni, I. Riederer, S. Chaouch, M. Belicchi, P. Razini et al., In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study, Mol Ther J Am Soc Gene Ther, vol.17, pp.1771-1779, 2009.

A. Rodriguez, D. Pisani, C. A. Dechesne, C. Turc-carel, J. Kurzenne et al., Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse, J Exp Med, vol.201, pp.1397-405, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00304039

M. Sampaolesi, Y. Torrente, A. Innocenzi, R. Tonlorenzi, D. 'antona et al., Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts, Science, vol.301, pp.487-92, 2003.

M. Sampaolesi, S. Blot, D. 'antona, G. Granger, N. Tonlorenzi et al., Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs, Nature, vol.444, pp.574-583, 2006.

N. M. Vieira, M. Valadares, E. Zucconi, M. Secco, C. R. Bueno et al., Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin, Cell Transplant, vol.21, pp.1407-1424, 2012.

G. Cossu, S. C. Previtali, S. Napolitano, M. P. Cicalese, F. S. Tedesco et al., Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy, EMBO Mol Med, vol.7, pp.1513-1541, 2015.

Y. Torrente, M. Belicchi, C. Marchesi, D. 'antona, G. Cogiamanian et al., Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients, Cell Transplant, vol.16, pp.563-77, 2007.

, Commission directive 2003/94/EC, Off J Eur Union, vol.46, pp.262-284, 2003.

J. Sheu, H. Klassen, and G. Bauer, Cellular manufacturing for clinical applications, Dev Ophthalmol, vol.53, pp.178-88, 2014.

D. Barnes and G. Sato, Serum-free cell culture: a unifying approach, Cell, vol.22, pp.649-55, 1980.

X. Jin, Q. Xu, K. Champion, and H. S. Kruth, Endotoxin contamination of apolipoprotein A-I: effect on macrophage proliferation-a cautionary tale, Atherosclerosis, vol.240, pp.121-125, 2015.

S. A. Kuznetsov, M. H. Mankani, and P. G. Robey, Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation, Transplantation, vol.70, pp.1780-1787, 2000.

C. Tekkatte, G. P. Gunasingh, K. M. Cherian, and K. Sankaranarayanan, Humanized" stem cell culture techniques: the animal serum controversy, Stem Cells Int, p.504723, 2011.

J. Van-der-valk, D. Mellor, R. Brands, R. Fischer, F. Gruber et al., The humane collection of fetal bovine serum and possibilities for serumfree cell and tissue culture, Toxicol In Vitro, vol.18, pp.1-12, 2004.

J. L. Spees, C. A. Gregory, H. Singh, H. A. Tucker, A. Peister et al., Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy, Mol Ther J Am Soc Gene Ther, vol.9, pp.747-56, 2004.

E. M. Horwitz, P. L. Gordon, W. Koo, J. C. Marx, M. D. Neel et al., Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone, Proc Natl Acad Sci U S A, vol.99, pp.8932-8939, 2002.

X. Zheng, H. Baker, W. S. Hancock, F. Fawaz, M. Mccaman et al., Proteomic analysis for the assessment of different lots of fetal bovine serum as a raw material for cell culture. Part IV. Application of proteomics to the manufacture of biological drugs, Biotechnol Prog, vol.22, pp.1294-300, 2006.

O. Karnieli, O. M. Friedner, J. G. Allickson, N. Zhang, S. Jung et al., A consensus introduction to serum replacements and serum-free media for cellular therapies, Cytotherapy, vol.19, pp.155-69, 2017.

C. Jochems, J. Van-der-valk, F. R. Stafleu, and V. Baumans, The use of fetal bovine serum: ethical or scientific problem?, Altern Lab Anim, vol.30, pp.219-246, 2002.

L. G. Chase, U. Lakshmipathy, L. A. Solchaga, M. S. Rao, and M. C. Vemuri, A novel serum-free medium for the expansion of human mesenchymal stem cells, Stem Cell Res Ther, vol.1, p.8, 2010.

S. Jung, A. Sen, L. Rosenberg, and L. A. Behie, Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells, Cytotherapy, vol.12, pp.637-57, 2010.

F. Mannello and G. A. Tonti, Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells, vol.25, pp.1603-1612, 2007.

K. Bieback, A. Hecker, A. Kocaömer, H. Lannert, K. Schallmoser et al., Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow, Stem Cells, vol.27, pp.2331-2372, 2009.

T. Kobayashi, H. Watanabe, T. Yanagawa, S. Tsutsumi, M. Kayakabe et al., Motility and growth of human bone-marrow mesenchymal stem cells during ex vivo expansion in autologous serum, J Bone Joint Surg Br, vol.87, pp.1426-1459, 2005.

A. Kocaoemer, S. Kern, H. Klüter, and K. Bieback, Human AB serum and thrombinactivated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue, Stem Cells, vol.25, pp.1270-1278, 2007.

L. Kyllönen, S. Haimi, B. Mannerström, H. Huhtala, K. M. Rajala et al., Effects of different serum conditions on osteogenic differentiation of human adipose stem cells in vitro, Stem Cell Res Ther, vol.4, p.17, 2013.

M. Patrikoski, M. Juntunen, S. Boucher, A. Campbell, M. C. Vemuri et al., Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells, Stem Cell Res Ther, vol.4, p.27, 2013.

A. Shahdadfar, K. Frønsdal, T. Haug, F. P. Reinholt, and J. E. Brinchmann, In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability, Stem Cells, vol.23, pp.1357-66, 2005.

N. Stute, K. Holtz, M. Bubenheim, C. Lange, F. Blake et al., Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use, Exp Hematol, vol.32, pp.1212-1237, 2004.

M. Yamaguchi, F. Hirayama, S. Wakamoto, M. Fujihara, H. Murahashi et al., Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion, Transfusion, vol.42, pp.921-928, 2002.

A. Poloni, G. Maurizi, F. Serrani, S. Mancini, G. Discepoli et al., Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate, Cell Prolif, vol.45, pp.66-75, 2012.

C. Dessels, M. Potgieter, and M. S. Pepper, Making the switch: alternatives to fetal bovine serum for adipose-derived stromal cell expansion, Front Cell Dev Biol, vol.4, p.115, 2016.

A. Muraglia, V. T. Nguyen, M. Nardini, M. Mogni, D. Coviello et al., Culture medium supplements derived from human platelet and plasma: cell commitment and proliferation support, Front Bioeng Biotechnol, vol.5, p.66, 2017.

J. Brun, T. Abruzzese, B. Rolauffs, W. K. Aicher, and M. L. Hart, Choice of xenogenicfree expansion media significantly influences the myogenic differentiation potential of human bone marrow-derived mesenchymal stromal cells, Cytotherapy, vol.18, pp.344-59, 2016.

D. M. Dohan-ehrenfest, I. Andia, M. A. Zumstein, C. Zhang, N. R. Pinto et al., Classification of platelet concentrates (platelet-rich plasma-PRP, plateletrich fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives, Muscles Ligaments Tendons J, vol.4, pp.3-9, 2014.

H. Lei, L. Gui, and R. Xiao, The effect of anticoagulants on the quality and biological efficacy of platelet-rich plasma, Clin Biochem, vol.42, pp.1452-60, 2009.

G. Weibrich, W. Kleis, G. Hafner, and W. E. Hitzler, Growth factor levels in plateletrich plasma and correlations with donor age, sex, and platelet count, J Cranio-Maxillo-Facial Surg, vol.30, pp.97-102, 2002.

P. Horn, G. Bokermann, D. Cholewa, S. Bork, T. Walenda et al., Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells, Cytotherapy, vol.12, pp.888-98, 2010.

T. Burnouf, D. Strunk, M. Koh, and K. Schallmoser, Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation?, Biomaterials, vol.76, pp.371-87, 2016.

C. Doucet, I. Ernou, Y. Zhang, J. Llense, L. Begot et al., Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications, J Cell Physiol, vol.205, pp.228-264, 2005.

M. Lohmann, G. Walenda, H. Hemeda, S. Joussen, W. Drescher et al., Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells, PLoS One, vol.7, p.37839, 2012.

D. Shih and T. Burnouf, Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion, New Biotechnol, vol.32, pp.199-211, 2015.

M. E. Bernardo, M. A. Avanzini, C. Perotti, A. M. Cometa, A. Moretta et al., Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute, J Cell Physiol, vol.211, pp.121-151, 2007.

E. Lucarelli, A. Beccheroni, D. Donati, L. Sangiorgi, A. Cenacchi et al., Platelet-derived growth factors enhance proliferation of human stromal stem cells, Biomaterials, vol.24, pp.3095-100, 2003.

N. Fekete, M. Gadelorge, D. Fürst, C. Maurer, J. Dausend et al., Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components, Cytotherapy, vol.14, pp.540-54, 2012.

N. Chevallier, F. Anagnostou, S. Zilber, G. Bodivit, S. Maurin et al., Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate, Biomaterials, vol.31, pp.270-278, 2010.

D. K. Krämer, K. Bouzakri, O. Holmqvist, L. Al-khalili, and A. Krook, Effect of serum replacement with plysate on cell growth and metabolismin primary cultures of human skeletal muscle, Cytotechnology, vol.48, pp.89-95, 2005.

H. Li, A. Usas, M. Poddar, C. Chen, S. Thompson et al., Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness, PLoS One, vol.8, p.64923, 2013.

R. Kelc, M. Trapecar, L. Gradisnik, M. S. Rupnik, and M. Vogrin, Platelet-rich plasma, especially when combined with a TGF-? inhibitor promotes proliferation, viability and myogenic differentiation of myoblasts in vitro, PLoS One, vol.10, p.117302, 2015.

A. Lardenois, S. Jagot, M. Lagarrigue, B. Guével, M. Ledevin et al., Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells, Proteomics, vol.16, pp.2028-2070, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01332030

F. Robriquet, A. Lardenois, C. Babarit, T. Larcher, L. Dubreil et al., Differential gene expression profiling of dystrophic dog muscle after MuStem cell transplantation, PLoS One, vol.10, p.123336, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01222898

K. Rouger, T. Larcher, L. Dubreil, J. Deschamps, L. Guiner et al., Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs, Am J Pathol, vol.179, pp.2501-2519, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00712818

F. Robriquet, C. Babarit, T. Larcher, L. Dubreil, M. Ledevin et al., Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation, BMC Musculoskelet Disord, vol.17, p.209, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01321085

J. Lorant, C. Saury, C. Schleder, F. Robriquet, B. Lieubeau et al., Skeletal muscle regenerative potential of human MuStem cells following transplantation into injured mice muscle, Mol Ther, vol.26, pp.618-633, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01673455

M. A. Blasco, H. W. Lee, M. P. Hande, E. Samper, P. M. Lansdorp et al., Telomere shortening and tumor formation by mouse cells lacking telomerase RNA, Cell, vol.91, pp.25-34, 1997.

J. Schindelin, I. Arganda-carreras, E. Frise, V. Kaynig, M. Longair et al., Fiji: an open-source platform for biological-image analysis, Nat Methods, vol.9, pp.676-82, 2012.

D. Cacchiarelli, C. Trapnell, M. J. Ziller, M. Soumillon, M. Cesana et al., Integrative analyses of human reprogramming reveal dynamic nature of induced pluripotency, Cell, vol.162, pp.412-436, 2015.

R. Edgar, M. Domrachev, and A. E. Lash, Gene expression omnibus: NCBI gene expression and hybridization array data repository, Nucleic Acids Res, vol.30, pp.207-217, 2002.

M. I. Love, W. Huber, and S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, vol.15, p.550, 2014.

B. Delorme and P. Charbord, Culture and characterization of human bone marrow mesenchymal stem cells, Methods Mol Med, vol.140, pp.67-81, 2007.

S. Wolbank, G. Stadler, A. Peterbauer, A. Gillich, M. Karbiener et al., Telomerase immortalized human amnion-and adipose-derived mesenchymal stem cells: maintenance of differentiation and immunomodulatory characteristics, Tissue Eng Part A, vol.15, pp.1843-54, 2009.

J. C. Pinheiro and D. Bates, Mixed-Effects Models in S and S-PLUS Springer Science & Business Media, 2009.

S. Chow, H. Wang, and J. Shao, Sample Size Calculations in Clinical Research Chapman & Hall/CRC, Biostatistics Series, 2003.

B. Delorme, J. Ringe, N. Gallay, L. Vern, Y. Kerboeuf et al., Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells, Blood, vol.111, pp.2631-2636, 2008.

A. Gunes, E. Iscan, H. Topel, S. T. Avci, M. Gumustekin et al., Heparin treatment increases thioredoxin interacting protein expression in hepatocellular carcinoma cells, Int J Biochem Cell Biol, vol.65, pp.169-81, 2015.

H. Yamaguchi, H. Yamashita, H. Mori, I. Okazaki, M. Nomizu et al., High and low affinity heparin-binding sites in the G domain of the mouse laminin alpha 4 chain, J Biol Chem, vol.275, pp.29458-65, 2000.

S. Viau, L. Chabrand, S. Eap, J. Lorant, K. Rouger et al., Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells, PLoS One, vol.12, p.181406, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02620790

S. Viau, L. Chabrand, S. Eap, J. Bouilliez, P. Bertholet et al., A standardized and characterized clinical grade human platelet lysate for efficient expansion of human bone marrow mesenchymal stem cells, ISCT Annu Meet Cytotherapy, vol.195, issue.5, p.279, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02624673

O. Miroshnychenko, W. Chang, and J. L. Dragoo, The use of platelet-rich and platelet-poor plasma to enhance differentiation of skeletal myoblasts, Am J Sports Med, p.363546516677547, 2016.

M. Wang, S. U. Amano, R. Flach, A. Chawla, M. Aouadi et al., Identification of Map4k4 as a novel suppressor of skeletal muscle differentiation, Mol Cell Biol, vol.33, pp.678-87, 2013.

T. Boome, L. Mansilla, C. Van-der-wagen, L. E. Lindemans, C. A. Petersen et al., Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells, Leukemia, vol.29, pp.1839-1885, 2015.

T. Bouckenooghe, P. Bertholet, L. Chabrand, S. Viau, and B. Delorme, Standardized and clinical grade human platelet lysate hydrogel (HPLG) for the optimization of large-scale expansion of human mesenchymal stem cells. 21st ISCT Annu Meet Cytotherapy, vol.17, p.69, 2016.

M. P. Mojica-henshaw, P. Jacobson, J. Morris, L. Kelley, J. Pierce et al., Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures, Cytotherapy, vol.15, pp.1458-68, 2013.

S. Laner-plamberger, T. Lener, D. Schmid, D. A. Streif, T. Salzer et al., Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate, J Transl Med, vol.13, 2015.

S. Viau, L. Chabrand, S. Eap, J. Bouilliez, P. Bertholet et al., A standardized and characterized GMP-compliant human platelet lysate for efficient expansion of human bone marrow mesenchymal stem cells. 21st ISCT Annu Meet Cytotherapy, vol.16, p.131, 2016.

A. Brunetti and I. D. Goldfine, Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor, J Biol Chem, vol.265, pp.5960-5963, 1990.

J. Massagué, S. Cheifetz, T. Endo, and B. Nadal-ginard, Type beta transforming growth factor is an inhibitor of myogenic differentiation, Proc Natl Acad Sci U S A, vol.83, pp.8206-8216, 1986.